Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages
about
Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis.Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endotheliumRole of angiopoietin-2 in corneal lymphangiogenesis.Effect of sorafenib in a murine high risk penetrating keratoplasty modelNovel characterization of lymphatic valve formation during corneal inflammationPhenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesisIncreased lymphangiogenesis and hemangiogenesis in infant corneaVery late antigen-1 mediates corneal lymphangiogenesis.Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.Conjunctival lymphatic response to corneal inflammation in mice.MicroRNA-184 Regulates Corneal Lymphangiogenesis.Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signalingVEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitisCXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.Expression of vascular endothelial growth factor C in human pterygium.Near-infrared lymphography as a minimally invasive modality for imaging lymphatic reconstitution in a rat orthotopic hind limb transplantation model.VEGF-C promotes the development of lymphatics in bone and bone loss.Expression of Lymphangiogenic Markers in Rejected Human Corneal Buttons after Penetrating Keratoplasty.
P2860
Q27301422-0EEAF7EC-4C90-4954-89C0-DA4DFFC61801Q28741586-623AFC33-44E1-4F9A-9EAC-4FED81574454Q33689659-09F927ED-976D-4AD3-9EDF-6480DA15C46EQ33914667-585C2112-3A50-4CF3-ADF6-F3ED2CEC6682Q33961587-88EE0D0F-D827-449D-8A9C-EC8A9E84D4C4Q34403458-48940BDA-0B2B-4A3E-9CB7-FC36BC8E2179Q35051497-F2BB7985-8930-489B-A78F-C6E500445076Q35220989-A4EFC342-65B0-49F2-A19D-C8F5051C70BBQ35221271-CAFD700A-130E-4D1E-A2DA-255E8EC06D7BQ35864899-9326A771-56D9-4AD4-B3D5-011CE1F0FB16Q36267878-3A35DD5B-8685-4C2A-8395-3CF0B0710F77Q36793577-A104D4AF-B2BA-4895-996C-7B4B5C3B9466Q37262772-887A0EEA-1756-4DB3-BF70-63261CFFB558Q37270675-9D9839A0-EC60-4A38-97CA-6DD76454923EQ40169045-1B7F4706-8F2E-4A37-8287-6EAACC6B99AFQ44050914-5FD1B619-570A-4BFC-84FB-C09285EA5693Q45425509-D01A2CDD-E065-4BBE-B8FA-D15D1C68F69BQ52605044-9B54880B-7564-46F8-BB90-C0DA520C64FBQ54187943-F4FAC82B-2880-4EC3-9191-C5B85AC0DAC9
P2860
Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@ast
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@en
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@nl
type
label
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@ast
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@en
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@nl
prefLabel
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@ast
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@en
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@nl
P2093
P2860
P356
P1476
Combined blockade of VEGFR-2 a ...... sis in early and middle stages
@en
P2093
Bronek Pytowski
P2860
P304
P356
10.1167/IOVS.10-6408
P407
P577
2011-04-20T00:00:00Z